Number of people requiring preventive treatment for schistosomiasis by country

Population requiring preventive chemotherapy for schistosomiasis.

Countries reporting
52
Highest
34.86 million people
Nigeria
Lowest
29,668 people
Indonesia
Median
2.85 million people
Years covered
15
2010–2024
Data points
769

What the numbers show

Number of people requiring preventive treatment for schistosomiasis is currently reported for 52 countries. The highest value is 34.86 million people in Nigeria; the lowest is 29,668 people in Indonesia.

The median across all reporting countries is 2.85 million people, and the mean is 4.94 million people.

The gap between the highest and lowest reporting country is a factor of about 1,175.

Over the past decade 31 countries rose and 21 fell. The largest increase was in Egypt (up 4,773.1%), and the largest decrease in South Africa (down 90.5%).

Number of people requiring preventive treatment for schistosomiasis: full country ranking

#Country LatestYear 10-year changeTrend
1 Nigeria 34.86 million people 2024 down 45.6% falling
2 Tanzania 21.35 million people 2024 up 98.3% rising
3 Democratic Republic of Congo 18.86 million people 2024 down 0.9% rising
4 Mozambique 18.41 million people 2024 up 42.8% rising
5 Ethiopia 16.07 million people 2024 down 30.8% falling
6 Madagascar 13.03 million people 2024 up 91.0% rising
7 Mali 10.32 million people 2024 up 71.4% rising
8 Malawi 10.17 million people 2024 up 41.7% rising
9 Ghana 8.31 million people 2024 down 11.3% rising
10 Cote d'Ivoire 8.30 million people 2024 up 82.3% rising
11 Uganda 7.98 million people 2024 down 23.3% flat
12 Cameroon 6.80 million people 2024 up 96.0% falling
13 Angola 5.62 million people 2024 up 23.0% rising
14 Rwanda 5.47 million people 2024 up 137.9% volatile
15 Sudan 5.12 million people 2024 down 40.1% rising
16 Niger 5.10 million people 2024 down 17.7% rising
17 Zambia 4.79 million people 2024 down 2.9% flat
18 Kenya 4.77 million people 2024 up 119.2% volatile
19 Burkina Faso 4.46 million people 2024 up 15.0% volatile
20 Guinea 4.21 million people 2024 up 94.1% rising
21 Yemen 3.85 million people 2024 down 58.6% falling
22 South Sudan 3.75 million people 2024 up 52.2% rising
23 Senegal 3.38 million people 2024 down 0.0% falling
24 Philippines 3.21 million people 2024 up 63.9% rising
25 Togo 3.19 million people 2024 down 17.1% rising
26 Egypt 2.98 million people 2023 up 4,773.1% volatile
27 Zimbabwe 2.71 million people 2024 down 16.7% falling
28 Liberia 2.49 million people 2024 up 128.1% rising
29 Brazil 2.21 million people 2024 up 46.4% rising
30 Benin 2.17 million people 2024 up 127.0% rising
31 Sierra Leone 1.94 million people 2024 up 29.6% rising
32 Central African Republic 1.91 million people 2024 up 109.9% rising
33 Chad 1.91 million people 2024 down 48.2% rising
34 Somalia 1.44 million people 2024 up 162.4% volatile
35 Burundi 936,720 people 2024 down 66.4% flat
36 Eritrea 813,233 people 2024 up 48.3% rising
37 Gambia 657,160 people 2024 up 235.6% volatile
38 Mauritania 596,151 people 2024 down 12.5% rising
39 South Africa 506,732 people 2024 down 90.5% falling
40 Eswatini 411,702 people 2024 up 30.2% rising
41 Guinea-Bissau 399,321 people 2024 up 111.8% rising
42 Gabon 204,568 people 2024 down 39.1% falling
43 Namibia 196,714 people 2024 down 58.2% falling
44 China 156,162 people 2018 up 30.6% rising
45 Congo 151,745 people 2024 down 55.7% rising
46 Equatorial Guinea 147,618 people 2024 up 167.0% rising
47 Botswana 128,785 people 2024 down 24.3% volatile
48 Laos 115,265 people 2024 up 24.5% volatile
49 Cambodia 98,416 people 2024 up 129.8% volatile
50 Venezuela 66,388 people 2024 down 2.4% flat
51 Sao Tome and Principe 42,776 people 2024 up 422.2% volatile
52 Indonesia 29,668 people 2024 up 6.1% volatile

About this data

Indicator
Number of people requiring preventive treatment for schistosomiasis
Unit
people
Source
World Health Organization (2025) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
52 places, 769 data points, 2010–2024
Last refreshed

Population requiring preventive chemotherapy for schistosomiasis.